Pick of the Week - September 14, 2025

Note: In the coming weeks, we will be changing the sending domain of our newsletter to air.withvincent.com. Please add this new domain to your safe sender list to ensure that our emails will continue to be delivered and not marked as spam. If you notice that you are suddenly not receiving our emails, this is why.

Christine Healey is the Founder of HEALEY PRE-IPO, a concierge Pre-IPO broker service helping people invest in private tech stocks – the simple, personal way. Previously, Christine was the Head of Private Markets at Destiny and the Portfolio Manager of Destiny’s Pre-IPO fund (NYSE:DXYZ), as well as early employee and Senior Director at Forge (NYSE:FRGE), working in both San Francisco and Hong Kong. Christine has closed ~$600m+ of private tech unicorn transactions to date and has spent close to a decade specializing in Pre-IPO investments. See healeypreipo.com for more information or to sign up for the mailing list.

SpaceX

Last valuation: $400 billion (reported tender offer in July), approximately $211.60 per share.

• SpaceX has historically shown dramatic growth

• Because it has tender offers every six to twelve months, there is visibility into the valuation growth of the company

• I am also interested in Anduril, which has also shown significant growth, and Neuralink, which is earlier on, but could be a really interesting growth story
  

Are you interested in buying shares of SpaceX, Anduril or Neuralink? See healeypreipo.com for more information.

Here’s a full list of all our past expert investing picks.

Join over 1 million people investing in founders building the future for as little as $100.

Offer: Get 30% off ($90 value) of a Wefunder VIP annual membership with code VINCENT.

Full list of exclusive offers for AIR subscribers.

<sub>Vincent Labs, Inc. nor our featured investment expert are not in the business of rendering personalized or individualized investment advice. We don't (and can't) know your financial situation, risk tolerances, or investing objectives. Accordingly, the information provided along with the decisions made and actions taken by the Service do not constitute a recommendation that a particular portfolio, security, strategy or action taken is suitable for you, or any specific person for that matter.

Neither Vincent Labs, nor its experts, writers or presenters of content will be liable for any investment decision you make, or action you take based upon reliance on any material you read here. Vincent Labs is a company of investors writing for investors and as such, the writers (and/or the company) may own stocks, ETFs, cryptocurrencies, or other digital assets mentioned.

Vincent Labs, Inc. strongly urges caution when considering these investments and encourages you to speak with your own financial and tax advisors before investing.</sub>